{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T00:48:00Z","timestamp":1755218880686,"version":"3.43.0"},"reference-count":15,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","license":[{"start":{"date-parts":[[2024,4,24]],"date-time":"2024-04-24T00:00:00Z","timestamp":1713916800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nd\/4.0\/ http:\/\/creativecommons.org\/licenses\/by-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n            <jats:title>Introduction:<\/jats:title>\n            <jats:p>Hyaluronic acid (HA) fillers, popular for facial cosmetic enhancements, pose risks of vascular complications like skin necrosis due to arterial blockage, necessitating effective treatments such as hyperbaric oxygen therapy (HBOT).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methodology:<\/jats:title>\n            <jats:p>This study presents a series of cases where measurements of transcutaneous oxygen pressure (TcPO<jats:sub>2<\/jats:sub>) informed the application of HBOT for skin necrosis induced by HA.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Clinical presentation and outcomes:<\/jats:title>\n            <jats:p>In cases 1 and 3, following the injection of HA, potential skin necrosis was observed. In addition to standard treatment, TcPO<jats:sub>2<\/jats:sub> revealed values below 40\u00a0mmHg, indicating tissue hypoxia. Treatment with HBOT increased TcPO<jats:sub>2<\/jats:sub> levels to above 200\u00a0mmHg, suggesting that HBOT could correct the hypoxia. Monitoring TcPO<jats:sub>2<\/jats:sub> levels also aided in determining the optimal time to discontinue HBOT. In cases 2 and 4, patients received standard treatment, resulting in TcPO<jats:sub>2<\/jats:sub> levels above 40\u00a0mmHg, indicating adequate tissue oxygenation, and no additional HBOT was administered. All four patients mentioned above showed good clinical recovery.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>This study investigates the application of TcPO<jats:sub>2<\/jats:sub> measurement technology in aiding decisions on whether to utilize HBOT in the treatment of complications arising from HA fillers, as well as in optimizing HBOT protocols.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/ms9.0000000000002033","type":"journal-article","created":{"date-parts":[[2024,7,5]],"date-time":"2024-07-05T14:04:29Z","timestamp":1720188269000},"page":"3827-3832","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Transcutaneous oxygen tension-guided hyperbaric oxygen therapy for preventing skin necrosis after hyaluronic acid filler injections"],"prefix":"10.1097","volume":"86","author":[{"given":"Qiqiong","family":"Yang","sequence":"first","affiliation":[{"name":"Department of Hyperbaric Oxygen, Chinese PLA General Hospital-Sixth Medical Center"},{"name":"The Second School of Clinical Medicine, Southern Medical University, Guangzhou, People\u2019s Republic of China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiyuan","family":"Shi","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Chinese PLA General Hospital-Fourth Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuyi","family":"Pan","sequence":"additional","affiliation":[{"name":"Department of Hyperbaric Oxygen, Chinese PLA General Hospital-Sixth Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hang","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Hyperbaric Oxygen, Chinese PLA General Hospital-Sixth Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2024,7]]},"reference":[{"key":"R1-20250806","first-page":"1088","article-title":"Consensus statement on prevention and management of adverse effects following rejuvenation procedures with hyaluronic acid-based fillers","volume":"31","author":"Philipp-Dormston","year":"2017","journal-title":"JEADV"},{"key":"R2-20250806","doi-asserted-by":"crossref","first-page":"961e","DOI":"10.1097\/PRS.0000000000002184","article-title":"Global aesthetics consensus: avoidance and management of complications from hyaluronic acid fillers-evidence- and opinion-based review and consensus recommendations","volume":"137","author":"Signorini","year":"2016","journal-title":"Plast Reconstr Surg"},{"key":"R3-20250806","doi-asserted-by":"crossref","first-page":"108862","DOI":"10.1016\/j.diabres.2021.108862","article-title":"Hyperbaric oxygen therapy for chronic diabetic foot ulcers: an overview of systematic reviews","volume":"176","author":"Wenhui","year":"2021","journal-title":"Diabetes Res Clin Pract"},{"key":"R4-20250806","first-page":"43","article-title":"Transcutaneous oximetry in clinical practice: consensus statements from an expert panel based on evidence","volume":"36","author":"Fife","year":"2009","journal-title":"Undersea Hyperb Med"},{"key":"R5-20250806","first-page":"3760","article-title":"Preferred reporting of case series in surgery (PROCESS) 2023 guidelines","volume":"109","author":"Mathew","year":"2023","journal-title":"Int J Surg"},{"key":"R6-20250806","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1177\/1090820X14525035","article-title":"Complications of injectable fillers, part 2: vascular complications","volume":"34","author":"DeLorenzi","year":"2014","journal-title":"Aesthet Surg J"},{"key":"R7-20250806","doi-asserted-by":"crossref","first-page":"e249190","DOI":"10.1136\/bcr-2022-249190","article-title":"Hyperbaric oxygen therapy for treatment of a late presenting ischaemic complication from hyaluronic acid cosmetic filler injection","volume":"15","author":"Jalilian","year":"2022","journal-title":"BMJ Case Rep"},{"key":"R8-20250806","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1097\/DSS.0000000000002109","article-title":"Hyperbaric oxygen therapy in hyaluronic acid filler-induced dermal ischemia","volume":"46","author":"Kruize","year":"2020","journal-title":"Dermatol Surg"},{"key":"R9-20250806","doi-asserted-by":"crossref","first-page":"246","DOI":"10.7181\/acfs.2019.00059","article-title":"Minimizing tissue damage due to filler injection with systemic hyperbaric oxygen therapy","volume":"20","author":"Hong","year":"2019","journal-title":"Arch Craniofac Surg"},{"key":"R10-20250806","doi-asserted-by":"crossref","first-page":"63","DOI":"10.2147\/CCID.S344408","article-title":"Hyperbaric oxygen therapy in managing minimally invasive aesthetic procedure complications: a report of three cases","volume":"15","author":"Oley","year":"2022","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"R11-20250806","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1097\/01.DSS.0000452637.52575.16","article-title":"Impending necrosis after injection of hyaluronic acid and calcium hydroxylapatite fillers: report of 2 cases treated with hyperbaric oxygen therapy","volume":"40","author":"Darling","year":"2014","journal-title":"Dermatol Surg"},{"key":"R12-20250806","doi-asserted-by":"crossref","first-page":"389","DOI":"10.22462\/07.08.2018.2","article-title":"Use of in-chamber transcutaneous oxygen measurement to determine optimal treatment pressure in patients undergoing hyperbaric oxygen therapy","volume":"45","author":"Heyboer","year":"2018","journal-title":"Undersea Hyperb Med"},{"key":"R13-20250806","first-page":"205","article-title":"A clinical practice guideline for the use of hyperbaric oxygen therapy in the treatment of diabetic foot ulcers","volume":"42","author":"Huang","year":"2015","journal-title":"Undersea Hyperb Med"},{"key":"R14-20250806","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1046\/j.1524-475X.2003.11610.x","article-title":"Hyperbaric oxygen therapy of diabetic foot ulcers, transcutaneous oxymetry in clinical decision making","volume":"11","author":"Niinikoski","year":"2003","journal-title":"Wound Repair Regen"},{"key":"R15-20250806","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1111\/jocd.12968","article-title":"Treatment of skin soft tissue embolism after hyaluronic acid injection for injection rhinoplasty in Asian patients","volume":"18","author":"HuaWei","year":"2019","journal-title":"J Cosmet Dermatol"}],"container-title":["Annals of Medicine &amp; Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MS9.0000000000002033","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T13:04:53Z","timestamp":1754485493000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MS9.0000000000002033"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,24]]},"references-count":15,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/ms9.0000000000002033","relation":{},"ISSN":["2049-0801"],"issn-type":[{"type":"electronic","value":"2049-0801"}],"subject":[],"published":{"date-parts":[[2024,4,24]]},"assertion":[{"value":"2024-03-04","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-03-28","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}